v3.22.2.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss $ (10,340,541) $ (9,226,136)
Adjustments to reconcile net loss to net cash used in operating activities:    
Fair value of common stock issued in exchange for services 88,500 2,551,000
Fair value of options issued in exchange for services 2,473,042 2,592,035
Impairment loss 111,817
Depreciation and amortization 28,395 22,602
Forgiveness of debt (95,425)
Decrease in assets    
Prepaid expenses 88,576 54,683
Increase (decrease) in liabilities    
Accounts payable and accrued expenses 603,214 382,187
Accounts payable and accrued expenses - related parties (130,560) (120,105)
Common stock to be issued 2,705,000
Net cash used in operating activities (4,484,374) (3,727,342)
CASH FLOWS FROM INVESTING ACTIVITIES    
Investment in patents (10,621) (41,196)
Net cash used in investing activities (10,621) (41,196)
CASH FLOWS FROM FINANCING ACTIVITIES    
Exercise of options 20,000
Proceeds from sale of Series B Preferred stock 4,164,249 475,020
Proceeds from 4% secured notes payable - stockholders 200,000
Repayment of notes payable - stockholders (50,000)
Proceeds from convertible notes payable - stockholders 4,770,000
Net cash provided by financing activities 4,364,249 5,215,020
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS (130,746) 1,446,482
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD 553,131 273,176
CASH AND CASH EQUIVALENTS - END OF PERIOD 422,385 1,719,658
Cash paid during year for:    
Interest 71,606
Income taxes
SUPPLEMENTAL DISCLOSURE OF NON-CASH FINANCING ACTIVITIES:    
Accrued preferred dividends 958,459 462,008
Options issued for software 111,817
Issuance of common stock for accounts payable 135,000
Conversion of Series A Preferred stock to common stock 11 61
affecting accumulated deficit 10,987,578
Exchange of deferred revenue for 10% convertible note payable 200,000
Cashless conversion of options into common stock 3
Exchange of note payable-stockholder and accrued interest for 4% convertible note payable $ 517,000